Results 61 to 70 of about 615,781 (294)

Direct Comparison of Therapeutic Effects on Diabetic Polyneuropathy between Transplantation of Dental Pulp Stem Cells and Administration of Dental Pulp Stem Cell-Secreted Factors

International Journal of Molecular Sciences, 2020
Stem cell transplantation is a potential novel therapy for diabetic polyneuropathy. Dental pulp stem cells (DPSCs) are attractive stem cell sources because DPSCs can be isolated from extracted teeth and cryopreserved while retaining viability.
Saki Kanada, Eriko Makino, N. Nakamura, Megumi Miyabe, Mizuho Ito, Masaki Hata, Taisuke Yamauchi, Noritaka Sawada, Shun Kondo, Tomokazu Saiki, T. Minato, K. Miyazawa, S. Goto, T. Matsubara, K. Naruse   +14 more
semanticscholar   +1 more source

Diabetic Polyneuropathy - Advances in Diagnosis and Intervention Strategies.

European Endocrinology, 2020
Over half of people with diabetes mellitus develop diabetic polyneuropathy (DPN), which is a major cause of reduced quality of life due to disabling neuropathic pain, sensory loss, gait instability, fall-related injury, and foot ulceration and amputation.
S. Tesfaye, G. Sloan
semanticscholar   +1 more source

Effectiveness of thioctic acid drugs (Espa-lipon) in the treatment of diabetic polyneuropathy

Медицинский совет, 2015
This article tells about the treatment of diabetic polyneuropathy - the most common neurological complications of diabetes mellitus. The pathogenesis, diagnosis and current evidence-based treatments are described. Thioctic acid drugs for the treatment of
M. V. Nesterova, V. V. Galkin
doaj   +1 more source

Falls in individuals with type 2 diabetes; a cross‐sectional study on the impact of motor dysfunction, postural instability and diabetic polyneuropathy

Diabetic Medicine, 2020
To estimate the incidence of falls in individuals with type 2 diabetes compared to healthy controls and to describe the characteristics of fallers with type 2 diabetes in relation to motor dysfunction, postural instability and diabetic polyneuropathy ...
K. Khan, R. Pop-Busui, Louise Devantier, A. G. Kristensen, H. Tankisi, U. Dalgas, K. Overgaard, H. Andersen   +7 more
semanticscholar   +1 more source

Matrix metalloproteinase-2 (MMP-2 ) and-9 (MMP-9) gene variants and microvascular complications in type 2 diabetes patients

Balkan Journal of Medical Genetics, 2023
Vascular complications are the leading cause of increased morbidity and mortality of diabetic patients. It has been postulated that matrix metalloproteinases MMP-2 and MMP-9, zinc-dependent endopeptidases through remodeling of the extracellular matrix ...
Andjelic Jelic M, Radojkovic D, Nikolic A, Rakicevic Lj, Babic T, Jelic D, Lalic NM   +6 more
doaj   +1 more source

Point‐of‐care nerve conduction device predicts the severity of diabetic polyneuropathy: A quantitative, but easy‐to‐use, prediction model

Journal of Diabetes Investigation, 2020
A gold standard in the diagnosis of diabetic polyneuropathy (DPN) is a nerve conduction study. However, as a nerve conduction study requires expensive equipment and well‐trained technicians, it is largely avoided when diagnosing DPN in clinical settings.
H. Kamiya, Yukauka Shibata, T. Himeno, Hiroya Tani, Takayuki Nakayama, K. Murotani, Nobuhiro Hirai, Miyuka Kawai, Yuriko Asada-Yamada, Emi Asano-Hayami, Hiromi Nakai-Shimoda, Yuichiro Yamada, Takahiro Ishikawa, Yoshiaki Morishita, Masaki Kondo, Shinichi Tsunekawa, Yoshiro Kato, M. Baba, J. Nakamura   +18 more
semanticscholar   +1 more source

Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy

Diabetologia, 2022
Aims/hypothesis No established blood-based biomarker exists to monitor diabetic sensorimotor polyneuropathy (DSPN) and evaluate treatment response. The neurofilament light chain (NFL), a blood biomarker of neuroaxonal damage in several neurodegenerative ...
H. Maalmi, A. Strom, A. Petrera, S. Hauck, K. Strassburger, O. Kuss, O. Zaharia, Gidon J. Bönhof, W. Rathmann, S. Trenkamp, V. Burkart, J. Szendroedi, D. Ziegler, M. Roden, C. Herder   +14 more
semanticscholar   +1 more source

ПРИНЦИПЫ ПАТОГЕНЕТИЧЕСКОЙ ТЕРАПИИ ДИАБЕТИЧЕСКОЙ АВТОНОМНОЙ НЕЙРОПА ТИИ

Архивъ внутренней медицины, 2012
According to WHO interpretation diabetic polyneuropathy, or chronic sensorimotor polyneuropathy, distal symmetrical polyneuropathy is a condition characterized by progressive loss of nerve fibers, leading to loss of sensation and the development of foot ...
А. А. Михайлов
doaj   +1 more source

Using Machine Learning Techniques to Identify Key Risk Factors for Diabetes and Undiagnosed Diabetes [PDF]

arXiv, 2021
This paper reviews a wide selection of machine learning models built to predict both the presence of diabetes and the presence of undiagnosed diabetes using eight years of National Health and Nutrition Examination Survey (NHANES) data. Models are tuned and compared via their Brier Scores.
arxiv  

Features of the influence of keltican and polarizing light on signs of neuropathic pain in combination therapy of diabetic polyneuropathy

Bolʹ, Sustavy, Pozvonočnik, 2018
Background. Diagnosis and treatment of diabetic polyneuropathy is of particular importance for patients with diabetes mellitus and can lead to severe consequences.
N.R. Makarchuk, L.P. Martynyuk
doaj   +1 more source